IRIS
CAVALLI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 680
NA - Nord America 545
AS - Asia 342
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 541
SE - Svezia 391
CN - Cina 163
SG - Singapore 159
IT - Italia 118
RU - Federazione Russa 96
FI - Finlandia 25
DE - Germania 18
IE - Irlanda 16
IN - India 9
GB - Regno Unito 6
NL - Olanda 5
CA - Canada 4
PH - Filippine 4
IR - Iran 3
EU - Europa 2
TN - Tunisia 2
AR - Argentina 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.574
Salva come PNG Salva come JPEG
Città #
Lawrence 107
Princeton 107
Singapore 105
Shanghai 70
New York 51
Ashburn 38
Moscow 38
Boardman 34
Milan 25
Helsinki 22
Dublin 16
Los Angeles 14
Seattle 14
Guangzhou 12
Rome 7
Bologna 6
Beijing 5
Pune 5
Saint Louis 5
Verona 5
Jiaxing 4
Mestrino 4
Quezon City 4
Ancona 3
Angera 3
Gallarate 3
Lappeenranta 3
London 3
Vittoria 3
Wuxi 3
Arnsberg 2
Balasore 2
Boltiere 2
Castel Mella 2
Foshan 2
Hyderabad 2
Nantong 2
Padova 2
Pisa 2
Quanzhou 2
Segrate 2
Torre Del Greco 2
Xi'an 2
York 2
Amsterdam 1
Baoding 1
Borås 1
Bratislava 1
Buenos Aires 1
Buffalo 1
Capaccio 1
Cesano Maderno 1
Chandler 1
Chelyabinsk 1
Dalian 1
Dallas 1
Fiumefreddo Di Sicilia 1
Florence 1
Gorodishche 1
Guayaquil 1
Gunzenhausen 1
Hanover 1
Issogne 1
Jakarta 1
Kassel 1
Kista 1
Lainate 1
Maidenhead 1
Modena 1
Nizhniy Novgorod 1
Oslo 1
Paliano 1
Parma 1
Perugia 1
Podgorica 1
Reeuwijk 1
San Diego 1
San Francisco 1
San Sperate 1
Santa Clara 1
Secaucus 1
Sezze 1
Shaoxing 1
Shenzhen 1
Taipei 1
Tel Aviv 1
Toronto 1
Torre Boldone 1
Washington 1
Wenzhou 1
Wilmington 1
Yangzhou 1
Totale 795
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 42
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 39
Testosterone in males with COVID-19: A twelve-month cohort study 34
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 33
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 28
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series 26
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 26
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 26
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 26
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 25
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 25
Advances in potential targeted therapies for Erdheim-Chester disease 23
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
A Novel Histiocytosis With Synovial and Skin Involvement 23
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 22
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 22
Autophagy and Protein Secretion 22
Anakinra for patients with COVID-19 – Authors' reply 22
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 21
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 20
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 20
An enlightening scan 20
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 20
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 20
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
A virus-free cellular model recapitulates several features of severe COVID-19 20
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients 20
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 19
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 19
Current treatment options and safety considerations when treating adult-onset Still’s disease 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. 18
Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms: do we really need it? 18
Anakinra therapy for non-cancer inflammatory diseases 18
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 17
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 17
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 17
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE 16
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series 16
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk 16
Anakinra for COVID-19: how to interpret elevations in serum liver enzymes 16
Testosterone in males with COVID-19: A 7-month cohort study 16
3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target 15
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition 15
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis 15
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease (Arthritis Research and Therapy (2019) 21 (54) DOI: 10.1186/s13075-019-1843-9) 15
The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease 14
Autoimmune vitiligo is associated with gain-offunction by a transcriptional regulator that elevates expression of HLA-A∗02:01 in vivo 14
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients 14
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease 13
Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation 13
CARDIAC CINE MRI IN ERDHEIM-CHESTER DISEASE: DATA FROM A LARGE ITALIAN COHORT 13
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case 13
Priorities of biomedical research 13
Myocarditis: An Interleukin-1-Mediated Disease? 13
Suppression of inflammation and acquired immunity by IL-37 13
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 13
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 13
Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis 13
Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness 13
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 13
Erdheim-Chester disease. 12
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab 12
Treating Pulmonary Silicosis by Blocking Interleukin 1 12
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance 12
Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer 12
Large Vessel Vasculitis Affecting the Aorta and Its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature 12
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients 12
The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity 12
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. 11
Hypertrophic cardiomyopathy secondary to hepatitis C virus-related vasculitis 11
Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease 11
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 11
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies 11
Treating Life-Threatening Myocarditis by Blocking Interleukin-1 11
Efficacy and safety of biological agents in adult-onset Still's disease 10
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 10
TUMOUR NECROSIS FACTOR-ALPHA AS A MASTER REGULATOR OF INFLAMMATION IN ERDHEIM-CHESTER DISEASE: RATIONALE FOR THE SUCCESSFUL TREATMENT OF TWO PATIENTS WITH INFLIXIMAB 10
Tocilizumab in patients with multisystem Erdheim–Chester disease 10
Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis: The Role of Cardiac Magnetic Resonance 10
Gender differences in clinical presentation and vascular pattern in patients with Takayasu arteritis 10
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout 10
CEREBROSPINAL-FLUID S-ADENOSYLMETHIONINE (SAME) AND GLUTATHIONE CONCENTRATIONS IN HIV-INFECTION - EFFECT OF PARENTERAL TREATMENT WITH SAME 10
Corrigendum: Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation [Rheumatology, 55, (2016), (2220-2229)] doi:10.1093/rheumatology/kew325 10
Prevalence of Takayasu arteritis in young women with acute ischemic heart disease 10
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 10
Cutaneous vasculitis following COVID-19 vaccination 10
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply 10
Diagnosing Erdheim-Chester disease 9
Letter by Campochiaro et al regarding article, “Clinical features, management, and outcomes of immune checkpoint inhibitor–Related cardiotoxicity” 9
Charcot's arthropathy of the hip 9
Charcot's arthropathy of the spine 9
CLINICAL PRESENTATION OF ERDHEIM-CHESTER DISEASE: DATA FROM A COHORT 8
Efficacy and Safety Of Biologic Agents In Adult-Onset Still's Disease: A Long-Term Follow-Up Of 19 Patients At a Single Referral Center 8
EFFICACY OF ORAL TACROLIMUS IN TWO PATIENTS WITH SCLERITIS AND RELAPSING POLYCHONDRITIS 8
Orthopnea with platydeoxia secondary to prominent Eustachian valve 8
Totale 1.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 0 0 0 0 55 1
2020/202150 2 0 5 5 0 12 9 3 2 4 6 2
2021/2022128 1 0 32 31 11 11 4 2 21 3 8 4
2022/2023678 240 157 53 5 12 81 27 52 33 2 8 8
2023/2024496 17 40 60 43 48 72 23 52 5 8 40 88
2024/2025354 179 31 37 51 56 0 0 0 0 0 0 0
Totale 1.789